Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006 Aug 03; 355(5):467-77.
View in:
PubMed
subject areas
ATP-Binding Cassette Transporters
Cohort Studies
Diabetes Mellitus
Female
Glyburide
Heterozygote
Humans
Hypoglycemic Agents
Infant
Infant, Newborn
Insulin
Insulin-Secreting Cells
Male
Mutation
Potassium Channels
Potassium Channels, Inwardly Rectifying
Receptors, Drug
Sulfonylurea Compounds
Tolbutamide